Eli Lilly quickly disassociated itself from Hims & Hers after the telehealth company said it was selling the pharmaceutical company’s weight-loss drug. Hours after Hims & Hers posted a blog ...

Eli Lilly is developing what could be the first oral GLP-1 agonist. Late-stage clinical trial data is coming this year. The stock has a steep valuation despite trading sideways since the summer ...

Inspired by true events, Sky Force unravels a compelling story that offers a glimpse into one of India’s first and deadliest airstrikes on Pakistan. The film follows the journey of a hero lost ...

Reserve your spot now. Eli Lilly And Co LLY, on Sunday, announced positive Phase 2 results for lepodisiran, an investigational small interfering RNA (siRNA) therapy designed to lower the ...

Information About Us Contact us Feedback Terms Of Service Privacy Policy Subscriber Agreement JPost Jobs Cancel Subscription Sitemap Customer Service JP Store ...

One of Tesla's earliest investors has told Sky News that Elon Musk should step aside as the carmaker's chief executive unless he gives up his new government job. Ross Gerber said in an interview ...

Sky Force OTT release: Akshay Kumar and Veer Pahariya's hit Bollywood movie Sky Force will soon be streamed globally on the Over-The-Top platform. Prime Video has announced the global streaming ...

Follow Bloomberg India on WhatsApp for exclusive content and analysis on what billionaires, businesses and markets are doing. Sign up here. Eli Lilly and Co. has begun selling its blockbuster ...

US-based pharmaceutical giant Eli Lilly has launched its diabetes and weight-loss drug, Mounjaro, in India, following approval from the Central Drugs Standard Control Organisation (CDSCO).

“Semaglutide generics will be priced almost 95% lower than [Eli Lilly'] current price,” said Vishal Manchanda, senior vice-president, institutional research at Systematix Group. With the drop ...

Senior tight end Eli Raridon is gearing up for his final year at Notre Dame. The former four star tight end first arrived on campus in 2022, but two major knee injuries early in his career ...